Here's Why Sage Therapeutics Gained 48.9% in January

Here's Why Sage Therapeutics Gained 48.9% in January

Source: 
Motley Fool
snippet: 

After sliding 41.8% in 2018, shares of Sage Therapeutics (NASDAQ: SAGE) jumped nearly 49% last month, according to data from S&P Global Market Intelligence. The sudden leap came after the company reported impressive results for SAGE-217 in a phase 3 trial studying the drug candidate as a potential treatment for postpartum depression.